Navigation Links
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Date:4/9/2008

expected to close in the second-quarter of 2008.

Takeda America Holdings, Inc., which is wholly-owned by Takeda, has established Mahogany Acquisition Corp. as a wholly-owned subsidiary to effect the transaction. In the merger that follows completion of the tender offer, Mahogany Acquisition Corp. will be merged into Millennium, and the surviving entity will be an indirect wholly-owned subsidiary of Takeda.

Conference Call and Webcast Information

Takeda will host a Japanese-language investors meeting in Japan on April 10 at 8:00 p.m. JST (7 a.m. EDT) and an investors conference call in English at 10:00 p.m. JST (9 a.m. EDT) to discuss the transaction. The phone number for the English conference call is 1-877-887-6076 and the participant PIN is 160938#. The conference call recording of both events will be available on Takeda's website at http://www.takeda.com within several days.

About Takeda

Founded in 1781 and located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products.

Additional information about Takeda is available through its corporate website, http://www.takeda.com .

About Millennium

Millennium, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
2. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
3. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
4. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
5. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
6. Aida Acquires High-Level Research Institute in China
7. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
8. China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.
9. Immucor To Acquire BioArray Solutions Ltd.
10. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
11. Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Vermillion, Inc. (Pink Sheets: VRML), a molecular ... Ph.D. Chief Scientific Officer, Senior Vice President, ... be joining its board of directors upon ... "Bill brings more than 20 years research ... said Gail Page, Vermillion Executive Chairperson. ...
(Date:12/14/2009)... Mass., Dec. 14 Boston Scientific Corporation (NYSE: ... a public offering of $2 billion aggregate principal amount ... statement. The public offering consists of $850 million ... of 6.00 percent notes due January 2020 and $300 ... Boston Scientific plans to use the net proceeds for ...
(Date:12/14/2009)... the delivery of Brookfield Engineering’s Powder Flow Tester – helping ... a smaller footprint and more compact design. , ... ... ThermoFab, a US-based thermoforming company, has completed the delivery of ... sheet metal to a plastic enclosure with a smaller footprint ...
(Date:12/11/2009)... December 10, 2009 miRagen Therapeutics, Inc., a ... developing innovative microRNA-based therapeutics for cardiovascular and muscle ... that microRNA-206 (miR-206) plays a crucial role in ... Lou Gehrig,s disease) and in neuromuscular synaptic regeneration ... December 11 issue of the journal Science ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2
... Cellumen, Inc. and Mayo Foundation,for Medical Education and ... apply cellular systems biology (CSB(TM)) profiling to,breast cancer ... breast cancer,patient profile test to improve diagnosis and ... to initiate an exciting research and development,program with ...
... 1 A highly sensitive, easy-to-use,test that accurately ... the Best New Veterinary Product for Diagnostics in ... PCR test was selected for its,excellence and innovation ... global community of animal sciences practitioners and,professionals. The ...
... Mich., Oct. 1 Assay Designs, Inc., a leading,provider of ... research markets, announced two key additions to its,senior leadership team: ... as Vice President, Research and Development. ... Amgen in Thousand Oaks, CA, where he was a ...
Other Biology Technology:BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards 2BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards 3Assay Designs(TM) Announces Additions to the Leadership Team 2
(Date:12/11/2009)... to identify and degrade the diverse types of defective ... The researchers Sabine C. Horn, Professor Thomas Sommer, Professor ... Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have ... an enzyme complex that plays a critical role in ... regulating the identification and disposal of various defectively produced ...
(Date:12/11/2009)... associate professor of anthropology at the University of Arizona, ... to understand how violence shapes the health of those ... her and her colleagues, research," Documenting the health consequences ... Kenya: A conceptual framework," is currently published in a ... in collaboration with the British medical journal the ...
(Date:12/11/2009)... ocean,s temperature variability and circulation system could help improve ... is affected more by surface warming than previously thought, ... factors such as sea level rise and ice volume ... found to result in a more vigorous deep ocean ... of large quantities of warm water, with possible impacts ...
Breaking Biology News(10 mins):MDC researchers identify a scaffold regulating protein disposal 2UA-led study grapples with health effects of low-intensity warfare 2New discoveries could improve climate projections 2Mediterranean Diet Plus Exercise Lowers Alzheimers Risk 54241 1Mediterranean Diet Plus Exercise Lowers Alzheimers Risk 54241 2Mediterranean Diet Plus Exercise Lowers Alzheimers Risk 54241 3Stephen H Feinstein Ph D of Kansas Elected NAMI National Board President 54238 1Hard To Treat Diseases 28HTDS 29 exclusive agent and partner of NCPC 54234 1Hard To Treat Diseases 28HTDS 29 exclusive agent and partner of NCPC 54234 2Hard To Treat Diseases 28HTDS 29 exclusive agent and partner of NCPC 54234 3
... award seed money grants of up to $200,000 ... alternative energy innovations for transportation. Each project must ... strong potential to eventually attract external funding and ... between U-M and a world-class research and development ...
... of Technology (TU/e) in The Netherlands will award an ... the Institute for BioNanotechnology in Medicine, at Northwestern University, ... of TU/e, on Friday, 24 April 2009. Stupp (57) ... matter and applications for complex molecular systems in biomedical ...
... practice of science, especially in the fields of biology ... the ability to study what was previously unobservable opened ... indispensable to clinicians and researchers who regularly diagnose medical ... results can often take hours or even days because ...
Other Biology News:Samuel Stupp to receive honorary doctorate from TU/e 2Next generation microscopy: No stain, big gain 2
AedestaTM Animal Organ/Tissue Perfusion Soln....
Reusble. Uses in conjunction with the Apoptotic Cell Isolation Kit....
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
...
Biology Products: